Back to Search Start Over

Scalable characterization of the PAM requirements of CRISPR-Cas enzymes using HT-PAMDA.

Authors :
Walton RT
Hsu JY
Joung JK
Kleinstiver BP
Source :
Nature protocols [Nat Protoc] 2021 Mar; Vol. 16 (3), pp. 1511-1547. Date of Electronic Publication: 2021 Feb 05.
Publication Year :
2021

Abstract

The continued expansion of the genome-editing toolbox necessitates methods to characterize important properties of CRISPR-Cas enzymes. One such property is the requirement for Cas proteins to recognize a protospacer-adjacent motif (PAM) in DNA target sites. The high-throughput PAM determination assay (HT-PAMDA) is a method that enables scalable characterization of the PAM preferences of different Cas proteins. Here, we provide a step-by-step protocol for the method, discuss experimental design considerations, and highlight how the method can be used to profile naturally occurring CRISPR-Cas9 enzymes, engineered derivatives with improved properties, orthologs of different classes (e.g., Cas12a), and even different platforms (e.g., base editors). A distinguishing feature of HT-PAMDA is that the enzymes are expressed in a cell type or organism of interest (e.g., mammalian cells), permitting scalable characterization and comparison of hundreds of enzymes in a relevant setting. HT-PAMDA does not require specialized equipment or expertise and is cost effective for multiplexed characterization of many enzymes. The protocol enables comprehensive PAM characterization of dozens or hundreds of Cas enzymes in parallel in <2 weeks.

Details

Language :
English
ISSN :
1750-2799
Volume :
16
Issue :
3
Database :
MEDLINE
Journal :
Nature protocols
Publication Type :
Academic Journal
Accession number :
33547443
Full Text :
https://doi.org/10.1038/s41596-020-00465-2